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Abstract
Paratuberculosis, a chronic disease affecting ruminant livestock, is caused by Mycobacterium avium subsp.
paratuberculosis (MAP). It has direct and indirect economic costs, impacts animal welfare and arouses public health
concerns. In a survey of 48 countries we found paratuberculosis to be very common in livestock. In about half the
countries more than 20% of herds and flocks were infected with MAP. Most countries had large ruminant
populations (millions), several types of farmed ruminants, multiple husbandry systems and tens of thousands of
individual farms, creating challenges for disease control. In addition, numerous species of free-living wildlife were
infected. Paratuberculosis was notifiable in most countries, but formal control programs were present in only 22
countries. Generally, these were the more highly developed countries with advanced veterinary services. Of the
countries without a formal control program for paratuberculosis, 76% were in South and Central America, Asia and
Africa while 20% were in Europe. Control programs were justified most commonly on animal health grounds, but
protecting market access and public health were other factors. Prevalence reduction was the major objective in
most countries, but Norway and Sweden aimed to eradicate the disease, so surveillance and response were their
major objectives. Government funding was involved in about two thirds of countries, but operations tended to be
funded by farmers and their organizations and not by government alone. The majority of countries (60%) had
voluntary control programs. Generally, programs were supported by incentives for joining, financial compensation
and/or penalties for non-participation. Performance indicators, structure, leadership, practices and tools used in
control programs are also presented. Securing funding for long-term control activities was a widespread problem.
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Control programs were reported to be successful in 16 (73%) of the 22 countries. Recommendations are made for future
control programs, including a primary goal of establishing an international code for paratuberculosis, leading to universal
acknowledgment of the principles and methods of control in relation to endemic and transboundary disease. An holistic
approach across all ruminant livestock industries and long-term commitment is required for control of paratuberculosis.
Keywords: Paratuberculosis, Control, Review, Prevalence, Cattle, Sheep, Goat, Camelid, Deer, Wildlife
Background
Paratuberculosis is a mycobacterial disease of ruminants
caused by Mycobacterium avium subsp. paratuberculosis
(MAP). It begins as a localised infection that may become
systemic and often results in chronic granulomatous en-
teritis leading eventually to weight loss, (diarrhoea in some
species) and death. This syndrome is also known as
Johne’s disease. Depending partly on how long it has been
present in a herd, it can manifest as isolated clinical cases
or persistent outbreaks. The pathogenesis of paratubercu-
losis is similar to tuberculosis and other mycobacterial dis-
eases, MAP being a specialised intracellular pathogen that
triggers a debilitating immunopathological response, sub-
clinical infections however being more common [1]. Most
species of ruminant livestock are susceptible to paratuber-
culosis. It is present in many countries and is perceived to
be an important disease for reasons including its impacts
on the economy, the impact of clinical disease on animal
welfare, and public health.
Why should it be controlled?
Economic impacts
Economic losses due to paratuberculosis are a key driver
to control MAP. While the economic losses in dairy cat-
tle have been extensively studied, the difficulties in
quantifying them have been highlighted in two reviews
[2, 3]. Losses to the dairy farmer consist of losses before,
during or after culling [4]. Losses before culling may in-
clude reduced milk production of variable magnitude [5–
10], increased somatic cell counts [7, 8, 10–12], increased
incidence of clinical mastitis [10, 13, 14], reduced fertility
[2, 15, 16], increased susceptibility to other diseases [17,
18] and costs of testing and treatment [4]. Cattle infected
with MAP have higher on-farm mortality and cull rates
[19–23], as do veal calves that originated from dairy herds
with paratuberculosis [24]. Because MAP infection is asso-
ciated with a lower body weight [25, 26], the slaughter
value of infected cattle is reduced [4, 19, 20, 27, 28]. Costs
after culling are the loss of unrealised future income by
culling an individual [4, 29, 30].
The total annual economic losses per cow in infected
USA dairy herds were estimated at US$21 to US$79 [20,
31–34] while those in infected Australian, Canadian,
French, and UK dairy herds were estimated at A$45-
A$88 [29, 35], CDN$49 [36, 37], €234 [38] and GBP27
[39], respectively. In ‘average’ Dutch dairy herds (both
infected and uninfected), these losses were estimated
at up to €67 per cow per year [32]. The effect of the
reduction in milk production caused by MAP infec-
tion in US dairy herds to the US economy was esti-
mated to be an annual loss of US$200 million ± US$
160 million [40].
In beef cattle, the losses due to MAP infections de-
pend on the markets targeted by the farmer. Pedigree
farmers selling breeder cattle are much more affected
than farmers selling all their cattle directly for slaughter
or to feedlots [41]. As with dairy cattle, test-positivity in
beef cattle was associated with lower cow fertility, weight
loss, and lower calf body weight at birth and at 205 days
of age [42]. Total annual losses per cow in the first 15–
20 years after MAP introduction in suckler herds were
estimated to be on average GBP16 in British herds [43]
and €40 in French herds [38], whereas in Dutch suckler
cow herds (both infected and uninfected) they were €10
(small herds) to €28 (large herds) [44]. Farmers and vet-
erinarians perceived the annual losses per cow in in-
fected suckler cow herds to be around on average US$16
to US$17 [45]. However, most of the potential losses due
to MAP infection are hidden or opportunity costs, not
out-of-pocket losses [46].
Published estimates of economic losses in other do-
mestic ruminant species are sparse. In an Australian
study of 12 sheep flocks, the average annual mortality
rate due to paratuberculosis varied between 6.2 and
7.8%, resulting in a decrease of the average gross margin
of between 6.4 and 8.5% [47]. However, in some Austra-
lian flocks, mortality approached 20% per annum [48].
In addition to mortalities, weight loss in affected sheep
is of economic importance [49]. Infected fine wool Me-
rino flocks in New Zealand lost US$1.5 per ewe annually
which was about 3-fold as much as in mutton breeds,
while a case fatality rate of 1.2–2.7% was the main cost
factor (Gautam et al. 2019, in press). The economic
losses of paratuberculosis to the British sheep industry
were estimated at GBP 0.4 to 32 million per annum, de-
pending on assumptions on the prevalence of infection,
the mortality rate and the replacement strategy [50]. A
recent economic study showed that MAP infection de-
creased the profit efficiency from 84 to 64% in Italian
dairy sheep and goat farms [51].
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In addition to the economic production losses de-
scribed above, indirect losses may arise from trade re-
strictions at both the international [52] and national
levels. For instance, at the national level, Dutch dairy
herds can only deliver milk to their milk processors if
they periodically test their herd and cull any test-positive
cattle [53]. Furthermore, it is important to realise that
production losses caused by MAP not only impact in-
fected farms, but also have a negative economic impact
on consumers [54]. Despite the magnitude of these eco-
nomic losses to both infected farms and consumers,
probably the most important economic driver to control
MAP infection in livestock is uncertainty about the po-
tential involvement of MAP in human disease [55, 56].
Even in the absence of a proven link between MAP and
human disease, the economic consequences of reduced
milk demand could be large if consumers’ perception of
risk is large or if risk-mitigation strategies were per-
ceived to be ineffective [57].
Potential public health implications There are myriad
publications concerning the link between MAP and dis-
eases in humans. The authors of a series of review arti-
cles with rigorous methodologies concluded that sources
of human exposure existed [58, 59], and “while the zoo-
notic potential of M. paratuberculosis cannot be ignored,
due to important knowledge gaps in understanding its
role and importance in the development or progression
of human disease, its impact on public health cannot yet
be quantified or described” [60] . Thus, MAP can infect
humans but the infection may or may not cause Crohn’s
disease, the condition with which MAP is most often
linked. Consequently, the reviewers concluded that steps
beyond the programs that the dairy and ruminant indus-
tries had already developed for animal health and eco-
nomic reasons could not be justified by public health
authorities [60]. In other words, there was reliance on
animal health authorities to take the lead in managing
the risk, i.e. to reduce the exposure of humans to MAP
by controlling paratuberculosis in livestock.
Trade of livestock A major conundrum exists regarding
trade of livestock and their products. Whereas members
of the World Trade Organization (WTO) are required
to take an “appropriate”, scientifically based level of
sanitary measures to protect human and animal health,
WTO members cannot discriminate between members
where similar conditions prevail, e.g. a WTO member
cannot require freedom of MAP in traded livestock if
they themselves do not carry out activities to document
such freedom [52]. The World Organization for Animal
Health (OIE), whose standards are recognised by WTO,
offers no guidance on paratuberculosis [61]. The Inter-
national Association for Paratuberculosis therefore
provided guidelines for movement of livestock, accord-
ing to the rules laid down in the Sanitary and Phytosani-
tary (SPS) Agreement of WTO [52]. Furthermore, the
parliament of the European Union (EU) in 2016 decided
to list diseases according to specific criteria through the
EU Animal Health Law [62]. This law should be imple-
mented in all member states of the EU in 2021 with spe-
cific rules for each disease.
The European Commission in 2016 asked the Euro-
pean Food Safety Authority (EFSA) for advice regarding
paratuberculosis, and EFSA proposed that paratubercu-
losis complied with the criteria to be categorized with
regards to movement control (Category D) and surveil-
lance (Category E) to avoid spread of MAP [56]. After
the exchange of views between European Commission
and Member States in the Standing Committee on
Plants, Animals, Food and Feed, paratuberculosis was fi-
nally included only under Category E (surveillance) for
the listed animal species Bison spp., Bos spp., Bubalus
spp., Ovis spp., Capra spp., Camelidae and Cervidae.
Category D and other categories were disregarded,
mainly due to the lack of individual animal sensitivity of
current diagnostic tests and the difficulties associated
with granting paratuberculosis free status to herds, areas
and countries. Somewhat paradoxically the same tests
are being used within countries for disease control pur-
poses (see below).
Epidemiology and pathogenesis of paratuberculosis
MAP infections occur. in domestic and wild ruminants
throughout the world, with some monogastric species
also having been reported as infected [56, 63]. Apparent
spillover or endemicity has been described in wildlife in
some countries, with economic consequences for farmed
wildlife and unknown consequences for conservation of
free-ranging wildlife, endangered species or those in cap-
tive breeding programs [64, 65]. Transmission of MAP
is often insidious [66]. No country can be considered
without risk of introduction of the disease. Thus, free-
dom from disease is challenging to document and re-
quires extensive surveillance and reporting. Sweden
claims to be free of paratuberculosis in cattle since 2008,
and Norway has had no known cases of paratuberculosis
since 2015.
The age-profile within herds and flocks is a factor in-
fluencing the occurrence of clinical disease because of
the long incubation period. While the onset of clinical
paratuberculosis is usually at adult ages, many individ-
uals become infected during the first weeks of life when
they are exposed to MAP from older animals shedding
the bacterium in their faeces. Infection at older ages is
also possible [67, 68]. MAP is mainly transmitted dir-
ectly by the faecal-oral route, including via faecal con-
tamination of the udder or pasture, but the formation of
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aerosols might take bacteria to environmental niches
from which it could spread to naive cattle [69]. Other
routes like in utero are not negligible [70]. Lower envir-
onmental exposures may explain why the disease is
much less prevalent in extensively raised beef cattle than
in intensively raised dairy cattle. Commonly in beef cat-
tle herds the animals are slaughtered before they reach
the more advanced stages of infection where heavy MAP
shedding occurs; thus there is less opportunity for envir-
onmental contamination. However, this does not explain
the widespread disease in small ruminants raised in ex-
tensive conditions like those in Australia or Spain. MAP
is resistant to acidic soils and low temperatures, includ-
ing freezing, but it seems to be less resistant in hot and
dry climates. Protected from sunlight, MAP survived for
up to 55 weeks in a dry fully shaded environment [71]. If
vegetation is removed and shading is limited, survival is
reduced to a few weeks [72].
Within species, some breeds of livestock are more
likely than others to develop clinical paratuberculosis in
a given time frame [73]. Further, associations between
susceptibility to paratuberculosis and specific genetic
markers have been demonstrated [74], notwithstanding
the problems of inconsistent phenotypic classification
[75, 76]. Based on histopathological evidence, latent
forms of the disease, probably representing varying de-
grees of resistance, account for the majority of all infec-
tions [77].
After oral exposure, the first site of MAP colonization
is the ileal and jejunal Peyer’s patch, an organized
lymphoid tissue in the intestinal mucosa and submucosa,
from where it spreads to the mucosal lamina propria
[78]. MAP shows a clear tropism for this site, exiting the
host via the intestinal lumen, thus explaining the main
route of spread in faeces [79]. The amount of mycobac-
teria shed in faeces is most relevant for transmission of
the infection through environmental contamination.
Practices and tools for the control of paratuberculosis
The introduction of MAP into a herd is often recognized
only after spread has occurred [66]. Control of paratu-
berculosis then depends on population-level measures
such as the culling of animals that are shedding MAP,
applying hygienic measures aimed at reducing infection
of neonatal/young stock, and vaccination. Epidemio-
logical models in dairy cattle suggest that test and cull
or actions targeting infection routes are effective strat-
egies to decrease MAP prevalence [80–82]. These results
are reflected in independent data from other herds [83,
84]. Another risk factor that can be managed is the
introduction of livestock onto the farm [83, 85]. How-
ever, based on studies conducted in several countries the
compliance of farmers with recommendations on con-
trol of paratuberculosis can be low [86, 87].
MAP control programs can have different goals ran-
ging from reduction of clinical cases and/or MAP preva-
lence in a herd, which has been shown to be feasible in
general [84, 88, 89], to eradication of MAP from the
herd, which can be achieved only in some herds [90, 91].
Stamping out can be mandated when the prevalence is
low to zero.
Depending on the goal, several control strategies
apply. One is the identification and elimination of clinic-
ally diseased and/or subclinically infected animals (‘test-
and-cull’) [92]. However, as a stand-alone measure this
will not eradicate paratuberculosis in the long term [93–
95]. A second strategy applicable to all species is the
prevention of MAP transmission within the herd by en-
hancing on-farm biosecurity especially during rearing of
young stock. The main intervention strategy in dairy cat-
tle operations is preventing calves from contacting the
faeces of adult cows [96]. This avoids faecal-oral trans-
mission and in practice is achieved by improving calving
area hygiene and management of colostrum/milk feed-
ing. A process called “snatching”, that involves removing
goat kids at birth and separating them from their dams,
was successfully used to sanitize goat herds in previously
endemic areas in Norway [97], and is used in the
Netherlands. Basic preventive measures concentrate on
improving hygiene measures in young stock raising [98]
but should be extended to all management areas to in-
crease success [32, 88]. Small-scale field trials as well as
simulation studies have shown that the most effective con-
trol strategy consists of a combination of ‘test-and-cull’
and increasing on-farm biosecurity [94, 99, 100]. The re-
sults of a modelling study indicated that improving calf
hygiene and ‘test-and-cull’ were both necessary to stabilize
the herd status, but reduced calf exposure was confirmed
to be the most influential measure, followed by testing fre-
quency and the proportion of infected animals that were
detected and subsequently culled [101]. Culling the pro-
geny of known infected cows may also be considered as
part of the control strategy as there is a significant rate of
in utero infection with MAP [70]. Considering the finite
environmental survival of MAP, pasture and grazing man-
agement can be utilised to reduce the exposure of exten-
sively grazed livestock [71, 72].
As a further tool, biosecurity measures have to be in
place to control the transmission between herds and to
protect MAP-negative herds from new infection or re-
introduction of MAP. The purchase of sub-clinically in-
fected animals is considered to be the main factor for
between-herd transmission [102]. Therefore, MAP-herd
status certification that reflects the risk of MAP trans-
mission by animals originating from that herd is essen-
tial [103, 104].
Vaccination of ruminants has been demonstrated in
controlled studies to be effective in reducing the clinical
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incidence of paratuberculosis, delaying the onset of the
disease and reducing faecal shedding of MAP, thus redu-
cing the economic losses as well as transmission of
MAP [105, 106]. There can be considerable benefit of
vaccination relative to the cost [107] but there does not
appear to have been a critical review of this topic. Vac-
cination is not widely used in paratuberculosis control in
cattle. This is because of the risk of interference with
intradermal testing for bovine tuberculosis [108–110].
Importantly and in contrast, in the Australian, Icelandic
and Spanish sheep industries, vaccination has been a key
element in control leading to a significant reduction in
within-herd prevalence [111, 112].
A very important element in MAP-control is commu-
nication to farmers and veterinarians about the import-
ance and the components of the program [113–115] and
the need to consider farmers’ attitudes towards the im-
plementation of control measures on their farms [116].
Diagnostic tests for paratuberculosis
Diagnostic tests used to detect paratuberculosis are gen-
erally imperfect yet most are useful if applied properly
when a specific purpose has been identified. Examples of
purposes are establishment of populations at low risk of
infection, reduction of economic impact in diseased ani-
mals, eradication, confirmation of clinical disease, sur-
veillance and prevalence estimation [117]. The purpose
defines the stage of disease that must be detected: “in-
fected” (MAP has colonised the animal’s tissues), “infec-
tious” (MAP is being shed in faeces) or “affected by
MAP” (the animal is clinically diseased) [118]. Detection
should result in a decision [119] which could, for ex-
ample, be culling an animal to reduce the transmission
of MAP or to reduce its suffering. The relevant stage of
the disease to target and the applicable diagnostic test
are linked. Case definitions and terminology are very im-
portant for consistent application of tests and interpret-
ation of test results [76].
A wide range of tests exist. In general, they can be
classified as tests for MAP, or tests for the host immune
response against MAP. Bacterial culture or polymerase
chain reaction (PCR) used for faecal samples are direct
measures of bacterial shedding of the individual, whereas
enzyme-linked immunosorbent assay (ELISA) used for
serum or milk, and agar gel immunodiffusion (AGID)
and complement fixation test (CFT) are measures of
humoral immune responses, also of the individual. Tests
for the humoral immune response are applicable in
more advanced stages of the pathogenesis associated
with major bacterial shedding, reduced milk yield and
reduced weight at slaughter [27, 120–122]. Immune re-
sponses detected by such tests are not always specific for
MAP infection [123], and similarly faecal tests may
detect MAP that has merely been ingested and then pas-
sively shed, i.e. without true infection [124].
Faecal culture and faecal PCR are widely used tests for
MAP, while ELISA is commonly used to detect an anti-
body response against MAP. AGID and CFT are less
commonly used and less sensitive compared to ELISA
[120, 125]. The choice between tests can be related to
costs and logistics [100, 126]. Even though the sensitivity
of serum ELISA is considerably lower than the sensitivity
of faecal culture or faecal PCR, its sensitivity is fairly
high in cattle in advanced stages of infection [118, 127]
and higher S/P readings are associated with a higher
proportion of cattle shedding MAP in their faeces [128].
A definitive diagnosis of MAP infection in the individual
may be made on gross and histopathological examin-
ation, but even this test is not perfect and may require a
high number of tissues to rule out infection [129].
The accuracy of diagnosis of the individual can be in-
creased significantly if the results for the individual are
used in context of historical results of the herd or flock
of origin [130, 131]. These results can include individual
diagnostics as mentioned above, or herd- or flock-level
diagnostics such as culture or PCR on environmental
samples [132] [133], or use of pooling [90, 126, 134,
135]. Herd- and flock level diagnostics can also be used
to inform risk mitigation strategies for the herd or flock.
If there are no historical results, different types of tests
can be used in parallel or in series to increase the sensi-
tivity or specificity, respectively.
The Ziehl-Neelsen (ZN) stain of faecal or tissue
smears may serve as a fast diagnostic tool to support
clinical diagnosis, but serum ELISA is superior for this
purpose [127, 136]. Skin testing to detect cell-mediated
immune responses is also an option [137, 138], but its
use may affect the skin test for Mycobacterium bovis.
Furthermore, detection of cell-mediated immune re-
sponses using the skin test or in vitro tests such as the
interferon-gamma release assay may merely reflect ex-
posure to MAP and not be related to infection status.
Lastly, bulk tank milk ELISA is also used on occasion,
but low within-herd prevalence usually precludes a prac-
tical application [139] even though there is statistical
evidence of diagnostic value [140, 141]. OIE [117] pro-
vides an overview of different tests for different pur-
poses, but a multitude of considerations are needed to
establish a useful test-strategy (see e.g. [142]).
History of paratuberculosis control programs
Control programs for paratuberculosis have existed since
early last century. Their chronology was documented by
Benedictus et al. [113]: the first programs were set up in
France in the 1920’s followed by the Netherlands in
1942, Great Britain and Norway in the 1960’s, then
Cyprus and the United States of America in the 1970s.
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Iceland had a program to control paratuberculosis in
sheep in the 1950s [112]. The Australian program began
in the 1990’s [143]. Control programs for paratuberculo-
sis were then implemented in other developed countries,
and excellent reviews of these cover the period up until
2012, bringing information together particularly for cat-
tle [144–147]. However, there are other important, sus-
ceptible, livestock species and since 2012 new programs
have commenced (e.g. Ireland, Italy) while others have
been discontinued or substantially modified (e.g.
Australia, United States of America). While recent
country-specific information may exist [148], in general
there is a lack of authoritative information and it is cur-
rently impossible to ascertain from any single source
what is being done about paratuberculosis in different
countries, or the reasons for coordinated action. Fur-
thermore, it is difficult to find information on the global
distribution of paratuberculosis. Consequently, animal
health authorities in many countries are not in a good
position to make recommendations to their own govern-
ments or domestic animal industries, and sometimes
they are forced to respond quickly to changing circum-
stances with incomplete information.
Scope of this study
The aims of this study were to assess the existence and
nature of control programs for paratuberculosis for the
period 2012–2018 in countries for which there is reliable
information. Further aims were to assess the rationale
for control programs, outcomes of past and current con-
trol programs, and to make general recommendations
for future control programs.
Methods
Participants
Collaborators in different countries were identified using
chain referral sampling commencing in November 2017
with an invitation to members of the governing board of
the International Association for Paratuberculosis (IAP),
a not for profit expert body with aims to promote know-
ledge about paratuberculosis (http://www.paratuberculo-
sis.net), to join a project team. Governing board
members are elected by general members of the IAP in
countries with multiple IAP members and hence were
likely to have strong interest in paratuberculosis control
and a network of expert contacts. Through a process of
sequential referral from the board members, and subse-
quently from those whom they nominated, the senior
author progressively invited experts to participate as col-
laborators. Criteria for nomination included: knowledge
of, or access to, detailed information about paratubercu-
losis and national and/or regional control programs in
cattle, sheep, goats, camelids, deer, wildlife or zoological
collections; approval from employer to participate (if
applicable); and willingness to work to a tight schedule
in 2018. Those who agreed were sent additional infor-
mation and asked to comment on the scope of the study
and to complete a detailed on-line questionnaire, which
was designed to collect information in a consistent man-
ner. Participants (n = 27) who were delegates to the 14th
International Colloquium on Paratuberculosis, Riviera
Maya, Mexico met face to face on June 6, 2018 to dis-
cuss the project, review the results of preliminary ana-
lysis and recommend topics for further exploration in
this paper. The outcomes were circulated to all partici-
pants for comment to inform the composition of this
report.
Questionnaire
A draft questionnaire was developed using an on-line
platform (Survey Monkey, San Mateo, A, USA) and pre-
tested on ten volunteer collaborators each of whom had
past experience with surveys for paratuberculosis, from
ten countries (Australia, Canada, Czech Republic,
Denmark, Germany, Ireland, the Netherlands, New Zea-
land, South Africa and Spain). Their comments were
used to improve the questionnaire, which was then
made available by an e-mail link to all participants. A
copy of the questionnaire is provided as Additional file 1.
Data were exported to Excel (Microsoft Corp., Redmond,
WA). To enable country-level assessment when more
than one questionnaire was completed for a given coun-
try (typically where there were separate responses for
different regions of a country), data were aggregated as
follows. For animals: the largest regional population on
the logarithmic scale was selected; numbers of farms
were summed; the midpoint of average herd sizes and
the overall minima and maxima were used. At country
level: the disease was considered notifiable if it was at re-
gional level; the highest prevalence estimate at regional
level was selected; Yes was selected if this was a re-
sponse in any region; the earliest year for all start events
and the latest year for end events were selected; all re-
sponses to open questions, and comments, from all re-
gions were concatenated; other data in separate fields at
regional level were brought to country level.
Statistical analyses
Summary statistics were calculated, and box-and-
whisker plots were created for numeric variables,
namely, number of farms and average, minimum and
maximum herd sizes. The y-axes of box-plots were log10
transformed to improve their interpretability as their
distributions were highly right skewed.
Frequency tables and bar charts were created for cat-
egorical variables such as animal population sizes, num-
ber of farms and herd/individual prevalence estimates
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for each species. Maps were prepared in Mapline (ver-
sion July 2018, www.mapline.com).
Source of herd and individual prevalence estimates for
each species were classified into (a) objective, if the
source was one of the following: apparent or true preva-
lence based on serology, apparent or true prevalence
based on individual or bulk milk ELISA, or apparent or
true prevalence based on faecal culture or PCR; (b) sub-
jective, if the source was one of the following: abattoir
monitoring, other active surveillance, passive surveil-
lance, or other; or (c) not applicable. Responses to open
questions were manually paraphrased using consistent
terms developed following assessment of all responses,
summarised into groups and tabulated for analysis.
The relationship between herd-level prevalence esti-
mates and log transformed herd size was determined
using ordinal logistic regression. Number of farms and
herd sizes were compared between countries with and
without a paratuberculosis control program using Wil-
coxon two sample tests. Statistical analyses were con-
ducted using SAS (© 2002–2012 by SAS Institute Inc.,
USA), whereas graphs were produced using R Version
3.5.1 [149] and Excel. Proportions were compared using
a two-sample two-sided binomial test in Genstat (VSN
International).
Definitions
Paratuberculosis
This was broadly defined as the disease (Johne’s disease),
which has characteristic pathology and may be clinical,
or infection with M. avium subsp. paratuberculosis
(MAP). The terminology used for paratuberculosis case
definitions is available elsewhere [76].
Control program
The scope for a livestock disease control program in
general was an ongoing process of measures intended to
interfere with the unrestrained occurrence of the disease
based on Thrusfield [150]. The measures must include
elements of planning, coordination, documentation and
evaluation, and may be conducted locally, regionally, or
nationally. Examples of measures included: estimation of
prevalence to inform the decision making; surveillance
to detect infected herds; control of the infection in in-
fected herds and flocks; measures to prevent introduc-
tion of a disease into free populations; certification of
herds and flocks as a low-risk source. Objectives may
range from preventing an increase in prevalence through
to eradication. Excluded from this definition were: work
done by an individual veterinarian on cases of disease on
a farm; a private herd health program (also known as a
private health and productivity scheme) offered by a vet-
erinarian to an individual herd/farm.
Results
Countries and geographic regions
Out of a total of 109 invitees, 83 accepted nominations
to collaborate in the project. Over 10 weeks between 26
February and 10 May 2018, 82 collaborators, working in-
dividually or as teams within a country, completed the
questionnaires. One participant died during the study so
that data were obtained for 48 of the 49 countries that
came together in the collaboration (Fig. 1): Argentina,
Australia, Austria, Bangladesh, Belgium, Bhutan, Brazil,
Canada, Chile, Colombia, Costa Rica, Czech Republic,
Denmark, Ecuador, Finland, France, Germany, Greece,
Iceland, India, Iran, Israel, Italy, Japan, South Korea,
Lesotho, Mexico, Nepal, the Netherlands, New Zealand,
Nigeria, Norway, Panama, Poland, Ireland, Slovenia,
South Africa, Spain, Swaziland, Sweden, Switzerland,
Thailand, United Kingdom, United States of America,
Uruguay, Venezuela, Zambia, and Zimbabwe. There
were six countries from Africa, 19 from Europe, two
from the Middle East, seven from Asia, two from
Fig. 1 Countries represented in this study
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Australasia, three from North America, two from Cen-
tral America and seven from South America. Informa-
tion was not available from Russia and Central Asia as
experts were either not identified or did not respond to
invitations following nomination. These countries repre-
sented a range of socioeconomic levels. Measured in
terms of the United Nations Development Program
(http://www.undp.org/content/undp/en/home.html) index
ranking, they ranged from 1 (most developed) to 160
(least developed) out of 188 countries. Median ranking
was 28.5 and the third quartile was 87.5, indicating that
the participating countries were skewed towards those of
higher socioeconomic status. More than one question-
naire was completed for the following countries to enable
region-specific information to be collated: Belgium (Wal-
lonia, and whole country), Canada (Alberta, Atlantic Prov-
inces, Ontario, and Québec), France (western France and
whole country), Germany (Lower Saxony, Thuringia, and
whole country), Spain (País Vasco, Castilla y Leon, Comu-
nidad Valenciana, Galicia, and Navarra) and the United
Kingdom (Great Britain, and Northern Ireland).
Within the broad geographic regions, the special inter-
ests of the collaborators included field aspects of disease
control, laboratory science, management and coordin-
ation of disease control, communications and education,
research and other skills related to disease control in-
cluding public health. Collaborators from all 48 coun-
tries had at least one special interest or skill area and
those from 38 countries had special interests in two or
more of these categories.
Animal populations at risk
All but one of 48 countries had at least two of the
major types of farmed ruminants (dairy cattle, beef
cattle, sheep, goats, camelids and deer), and 38 coun-
tries (79%) had at least three (Table 1). Considering
also other farmed ruminants (for example buffalo,
bison), all 48 countries had at least three types or
species and two thirds of the countries (65%) had six
or seven types/species.
About 70% of countries had more than 1 million cat-
tle, sheep or goats and 20% of them had more than 10
million. Beef cattle and sheep were the most numerous
of the livestock types; ten countries had > 10 million beef
cattle while eight had more than 10 million sheep
(Table 2). Goats were the second most numerous type of
livestock; five countries had > 10 million. Three coun-
tries had > 10 million dairy cattle whereas 20 countries
had between 1 and 10 million. Dairy cattle, sheep and
goats were present in all 48 countries, while beef cattle
were not farmed in three countries (Bhutan, India,
Nepal). Camelids and deer were the ruminants that were
least often farmed, being reported in populations > 1000
from 12 countries and 15 countries, respectively. Coun-
try level data are provided in Additional file 2: Table S1.
Median number of farms per country was highest for
beef cattle (108,723), followed by sheep (36,313) and
dairy cattle (21,090), whereas median herd sizes were
highest for dairy cattle (108), sheep (68) and beef (50)
. Box-and-whisker plots for the numbers of farms and
herd sizes are presented in Additional file 3: Figure
S1 to S4). These data are addressed further in the
context of control programs for paratuberculosis in
the section below.
Notifiability of paratuberculosis
Paratuberculosis was notifiable to the relevant authority
in at least one of the farmed species in 35 (73%) of 48
countries, but the obligation to notify depended on the
species affected (Table 3). Not all species were present in
each country. It was notifiable regardless of species in
Australia, Finland, Norway and Sweden and in all of the
farmed species present in 32 countries. However, in
eight countries (Argentina, Austria, Italy, Mexico,
Slovenia, South Africa, United Kingdom, Venezuela) no-
tification was not required for some species that were
present, typically camelids and deer. In dairy cattle, it
was notifiable in 35 of 48 (73%) countries. In beef cattle
it was notifiable in 33 (73%) of the 45 countries in which
this type of ruminant was farmed, in sheep and goats in
28 (64%) of 44 countries, in camelids in 12 of 28 (43%)
countries and in farmed deer in 15 (50%) of 30 coun-
tries. It was notifiable in buffalo in Colombia, Brazil,
Italy, Japan and Switzerland and in bison in Canada and
Switzerland.
Paratuberculosis was not notifiable in any species in
13 (27%) of 48 countries which were not clustered in
any particular geographic region: Belgium, Czech Repub-
lic, Denmark, Ecuador, France, Greece, India, Iran, the
Netherlands, New Zealand, Nigeria, United States of
America, and Uruguay (see Additional file 2: Table S2).
Table 1 Distribution of farmed ruminant types and species
among 48 countries
No. types
of
ruminants
No. countries
Dairy cattle, beef cattle,
sheep, goats, camelids or deer
All types of farmed
ruminants
1 1 –
2 9 –
3 7 1
4 3 9
5 15 7
6 13 17
7 – 14
Total 48 48
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Under-reporting
Paratuberculosis was believed to be under-reported in 26
(74%) of the 35 countries in which it was notifiable, re-
gardless of the geographic zone. The reasons given for
under-reporting in decreasing order of frequency included
lack of knowledge (farmer or veterinarian) or awareness of
the clinical signs of disease (eight countries), reluctance to
report due to farmer concerns about the consequences of
quarantine or other action (5), lack of surveillance (4), no-
tification only of clinical cases (3), poor diagnostic tests
(2), lack of concern about paratuberculosis from govern-
ment (2), lack of application of national legislation (1),
government not notifying OIE (1), listing too recent for
notification (1), deliberate choice of tests, the results of
which are not notifiable (1), farmer culling of cases to
avoid detection (1), and farmer fear of the stigma of iden-
tification as a positive herd (1). There are also procedural
causes of under-reporting, such as testing animals of rela-
tively young age; this was cited by Italy where the product-
ive life of dairy cows averages only 2.6 lactations.
Prevalence of paratuberculosis
Herd-level prevalence
Notwithstanding missing information or unknown
situations in some countries and even though a dis-
tinction could not be made between apparent and
true prevalence (Tables 4 and 5), paratuberculosis was
relatively common. Based on objective laboratory test
data, herd-level prevalence < 1%, which may be con-
sistent with definitions of freedom, was a feature in
very few countries, for example 2 of 31 countries with
prevalence data for dairy cattle and 2 of 15 countries
with prevalence data for sheep (Table 4). But in 58%
of the 31 countries where there were prevalence esti-
mates, > 20% of cattle, sheep or goat herds were in-
fected. Similar proportions were observed where
prevalence had been estimated from non-laboratory
data (Table 4). Herd-level prevalence by country for
each type of ruminant is presented in Additional file 2:
Table S3.
For dairy cattle there was a significant association be-
tween herd size and herd-level prevalence of paratuber-
culosis (P = 0.001); for each one log increase in herd size
the odds of a country having a higher category of
prevalence increased by 9.7 (95% confidence limits
1.9–48.8). There were many missing data for either
herd size or prevalence (20 countries had missing
values for dairy cattle compared to 30 for beef cattle,
35 for sheep, 35 for goats and 45 for farmed deer;
camelids had very few observations).
Within-herd prevalence
Based on objective laboratory test data, within-herd
prevalence in infected herds of < 1% was a feature in
Table 2 Size of populations of each of the livestock types among 48 countries. Data are the number of countries
Population size Dairy cattle Beef cattle Sheep Goats Camelids Deer-farmed Other
< 1000 1 2 9 5 2
1000 to 10,000 1 1 1 8 6 8 3
10,000 to 100,000 2 2 7 14 1 5 2
100,000 to 1 million 20 13 15 7 7 2 6
1 million to 10 million 20 18 16 12 2
> 10 million 3 10 8 5 2
Unknown 2 1 9 9 5
Not applicable 3 16 19 26
Total 48 48 48 48 48 48 48
Table 3 Notifiability of paratuberculosis in each type of ruminant in 48 countries
Species/
type
No. of countries % countries in which species is
applicable and paratuberculosis
is notifiable
Notifiable Not notifiable Not applicable
Dairy cattle 35 13 72.9
Beef cattle 33 12 3 73.3
Sheep 28 16 4 63.6
Goats 28 16 4 63.6
Camelids 12 16 20 42.9
Deer-farmed 15 15 18 50.0
Other 10 11 27 47.6
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very few countries, for example 1 of 32 countries with
dairy cattle and 3 of 21 countries with beef cattle
(Table 5). But within-herd prevalence > 10% for most
species was common and > 15% was observed in at least
10% of countries. Similar proportions were observed
where prevalence had been estimated from non-
laboratory data (Table 5). Within-herd prevalence was
often unknown (in 12 countries with dairy cattle, 18
with beef cattle, 26 with sheep and 27 with goats).
Within-herd prevalence by country for each type of ru-
minant is presented in Additional file 2: Table S4.
Under-estimation of prevalence
Prevalence was believed to be underestimated in 29
(60%) of 48 countries regardless of the geographic zone.
Where reasons were given, in decreasing order of fre-
quency they included: the type of tests used underesti-
mate true prevalence (14 countries), lack of surveillance
(12), lack of knowledge (farmer or veterinary) or aware-
ness of the clinical signs of disease (2), reluctance to re-
port due to farmer concerns about the consequences of
quarantine or other action (1) and lack of concern about
paratuberculosis from government (1).
Free-living ruminants and wildlife
Wildlife were known to have paratuberculosis in 18
(38%) of 48 countries which were not clustered in any
particular geographic zone, but the situation was un-
known in 26 countries (54%). Data were not available to
separate infection with MAP from disease (pathology
associated with MAP infection) in these hosts. Often the
hosts were known to be in contact with farmed live-
stock. The list of species affected was extensive and in-
cluded omnivorous, herbivorous and carnivorous
mammals, including herbivorous marsupials, and even
some birds as shown in Additional file 2: Table S5.
Control programs for paratuberculosis
A total of 22 (46%) of 48 countries had a control pro-
gram for paratuberculosis in the period 2012 to 2018,
i.e. one that commenced, was operating or ended in this
period (Fig. 2) (Additional file 2: Table S6). Three of
these countries had a prior program that ended before
2012, while 20 of them had a long-term program that
will end after 2018. These long-term programs began as
early as 1942 in the Netherlands and 1962 in Iceland,
compared to as late as 2009 in New Zealand, with a me-
dian year of 2000. Seven countries indicated that they
will commence a new program in the period 2018–2020,
including Chile and Slovenia, neither of which had had
control programs before, and five countries which
already had a control program in 2012–2018. Only two
countries had a control program with a nominated end
date, Australia (2018) and Canada (2018). Thus control
programs began at different times and changed over
time in each country. Major chronological events in the
control programs in 22 countries are summarised in
Additional file 2: Table S7.
While countries with a control program represented
most geographic regions, more than half (14) were in
Table 4 Herd-level paratuberculosis prevalencea estimates in countries where laboratory testing had (or had not) been conducted.
Data are the number of countries at each prevalence level
Herd-level prevalence (%)a Dairy cattle Beef cattle Sheep Goats Camelids Deer-farmed
< 1 2 (1) 3 (3) 2 (1) 4 (2) 3 (1) 1 (1)
1–10 6 (2) 4 4 (2) 1 (1) 1
10–20 3 4 1 1 1
20–40 3 (1) 3 (1) 2 2
> 40 13 1 (1) 2 (1) 4 (1)
Total 27 (4) 15 (5) 11 (4) 12 (3) 4 (1) 2 (2)
aThe definition of prevalence and the way it was measured may have differed between countries and between species within countries
Table 5 Animal-level (within infected herds) prevalencea estimates in countries where laboratory testing had (or had not) been
conducted. Data are the number of countries at each prevalence level
Within-herd prevalence (%) Dairy cattle Beef cattle Sheep Goats Camelids Deer-farmed
< 1 1 3 (1) 1 (1) 2 1 (1) 1 (1)
1–5 5 6 (2) 2 2
5–10 10 5 2 2 (1) 1
10–15 7 (1) 2 (1) 1
> 15 3 2 2 3
Total 26 (1) 16 (3) 9 (2) 10 (1) 1 (1) 2 (1)
aThe definition of prevalence and the way it was measured may have differed between countries and between species within countries
Whittington et al. BMC Veterinary Research          (2019) 15:198 Page 10 of 29
Europe. The majority of countries without a control pro-
gram for paratuberculosis were in South and Central
America, Asia and Africa (19 of 25 countries) and only 5
(20%) were in Europe (Table 6).
Using the United Nations Development Program index
ranking for 2015, countries without a paratuberculosis
control program (median 73, range 19–160) were more
disadvantaged than those that had one (median 14,
range 1–119).
Number of farms or average herd size did not differ
between countries with and without a paratuberculosis
control program (Additional file 3: Figure S1-S4). How-
ever, minimum herd size for camelids was larger in
countries with a control program (p = 0.046) and the
maximum herd sizes for dairy cattle, beef cattle and
sheep were larger for countries with a control program
than those without a control program (p = 0.04, p = 0.03
and p = 0.03, respectively).
Reasons for having a control program for
paratuberculosis
All 22 countries with a control program for paratubercu-
losis cited animal health as a reason for having a control
program, whereas 90% cited reducing the economic or
production losses (Table 7). Maintaining regional or
international trade was a driver for 15 countries (68%)
followed by animal welfare in 11 (50%). Public health
was cited by eight countries (36%) in Asia (Japan, Korea
and Thailand), Europe (Austria, Belgium, Germany and
Republic of Ireland) and North America (Canada) as a
reason for having a control program. An explicit state-
ment regarding public health existed in the control pro-
gram documentation or information of five countries
(23%) (Austria, Germany, Japan, New Zealand and
United Kingdom), two of which did not cite public
health as a primary reason for having a control program.
The Republic of Ireland made reference to providing
“additional reassurance to the marketplace in relation to
Ireland’s efforts to control Johne’s disease” in the
programme objectives (http://animalhealthireland.ie/
?page_id=340) while in the United Kingdom there was a
general statement referencing the United Kingdom Food
Standards Agency policy towards Johne’s disease and hu-
man health, advising that the precautionary principle is
Fig. 2 Countries represented in this study that had a control program for paratuberculosis between 2012 and 2018
Table 6 Number of countries with a paratuberculosis control
program between 2012 and 2018 in each major geographic
region
Geographic region No. of countries with a
paratuberculosis control
program between 2012
and 2018
No. countries in this study
Africa 1 6
Asia 3 7
Australasia 2 2
Europe 14 19
Middle East 0 2
North America 2 3
Central America 0 2
South America 0 7
Total 22 48
Table 7 Primary reasons for having a control program among
22 countries
Reason No. of
countries
% of
countries
Animal health 22 100
Reducing production losses 20 90
Maintaining trade, regional or international 15 68
Animal welfare 11 50
Public health 8 36
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adopted (https://www.afbini.gov.uk/articles/johnes-dis-
ease).
Reasons for not having a control program for
paratuberculosis
Of the 26 countries that did not have a program for
paratuberculosis, nominated reasons were (Table 8): eco-
nomic constraints, insufficient animal health resources
beyond those already deployed to tackle other priority
diseases, a lack of animal health capacity (including in-
frastructure, operational resources, laboratory diagnostic
services) and lack of feasibility due to inadequate control
tools such as poor diagnostic tests and poor vaccines. In
some countries paratuberculosis was deemed not preva-
lent at herd or individual animal levels and was not con-
sidered to be a problem relative to other animal health
issues or it was present but was not considered to affect
the animal population. The availability of paratuberculo-
sis vaccine for use by farmers was cited as a reason for
not requiring a control program by one country. Other
reasons were given by ten countries including: paratu-
berculosis is not perceived as an immediate problem;
there is lack of interest from farmers due to legislative
restrictions; bureaucratic ignorance; cessation of funding;
lack of resources for collaboration between agencies and
regulatory authorities; and lack of cost-benefit except for
culling clinical cases.
Control programs for other diseases of livestock
Control programs for diseases other than paratuberculo-
sis were present in many countries. Bovine tuberculosis
(38 countries), bovine brucellosis (39), rinderpest (9) and
foot and mouth disease (32) control programs are exam-
ples, while programs for other diseases of livestock were
present in 42 countries. Countries without a control pro-
gram for paratuberculosis were neither more nor less
likely to have a control program for one of the other dis-
eases (Additional file 2: Table S8). Countries with a
control program for one of the other major livestock dis-
eases were neither more nor less likely to have a control
program for paratuberculosis.
Veterinary services on paratuberculosis for farmers
beyond control programs
Services offered by veterinarians or others for individual
farms included herd health programs in 27 of 48 coun-
tries and advice on paratuberculosis for individual ani-
mals in 32 of 48 countries. While the herd health
services were available in a similar proportion of coun-
tries with or without paratuberculosis control programs
(14/22 and 13/26 countries, respectively; P = 0.34), ad-
vice to farmers on individual cases of paratuberculosis
was available in fewer countries without a control pro-
gram for paratuberculosis than in countries with a con-
trol program for paratuberculosis (12/26 and 20/22,
respectively; P = 0.001) (Fig. 3).
Geographic organization of paratuberculosis control
programs
It was very difficult to classify control programs strictly
as regional or national. For example, in both Australia
and Germany there was a national control program
agreed through consensus of the regions, each of which
had a State Government with jurisdictional control over
biosecurity. In this case the programs were implemented
and controlled by State jurisdictions, i.e. regionally, and
they could differ from region to region in key aspects.
There were also differences in the species included in
control programs between countries. The geographic
organization of paratuberculosis control programs are
summarised by country and species in Additional file 2:
Table S9.
Eighteen of 22 countries had a single national control
program for the relevant species, while five had regional
control programs (Belgium, Canada, Germany, France
and Spain) that operated in some or most regions of the
country, depending on the species. Two countries had
Table 8 Reasons stated for not having a control program for paratuberculosis among 26 countries
Reason No. countries % countries
Economic constraints 12 46
Animal health resources are currently deployed to tackle other priority diseases 11 42
Other 10 40
Lack of national/regional animal health capacity, infrastructure or operational resources 8 31
Paratuberculosis is not prevalent at herd or individual animal levels and is not considered to be a
problem relative to other animal health issues
8 31
Lack of laboratory diagnostic services 6 23
Paratuberculosis is present but is not considered to affect the animal population 5 19
Lack of feasibility due to inadequate control tools (eg. poor diagnostic tests, poor vaccines) 1 4
Paratuberculosis vaccine is available for use by farmers (there is no coordinated control program) 1 4
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more than one national control program for dairy and/
or beef cattle while having a single national control pro-
gram for other types of livestock (the Netherlands,
United Kingdom). The regional program activities of re-
gional or national programs were co-ordinated regionally
in some countries (Australia, Belgium, Canada, France,
Germany, Spain and United Kingdom) and nationally in
all other countries. The control programs operating within
species in different regions of a country were different
from one another in some countries (Australia, Belgium,
France, and Germany), but similar or identical to one an-
other in other countries (Iceland, Korea, Spain, Thailand
and the United Kingdom). In Canada, they were similar or
identical in dairy cattle but different in beef cattle.
Objectives of control programs
The number of objectives specified by a country and the
level of detail in each objective varied between countries and
sometimes the methods of achieving an objective was
expressed within the objective. This made assessing objec-
tives difficult, and sometimes it was unclear whether objec-
tives expressed were comprehensive statements or whether
the descriptions were directly correlated with program activ-
ities. Furthermore, objectives may have differed between the
different types of livestock in a country. For example, two
countries, Australia and the Netherlands, expressed their
control program objectives differently for different livestock
industries (dairy cattle, beef cattle and small ruminants).
Logically, program objectives and design reflected the
stage of paratuberculosis control and initial prevalence.
For example, stamping out and then ongoing surveil-
lance was the goal in countries where the disease was
very uncommon or absent (such as Sweden and Norway)
compared to culling cases in countries where the disease
was common. For simplicity, the objectives were aggre-
gated across types of livestock and are presented in
Table 9. The most common objective, expressed by 77%
of countries with a control program, was to reduce the
prevalence of MAP infection, followed by the related ob-
jective of reducing the incidence of clinical cases (45% of
countries). The methods of doing so while also reducing
spread to other herds was expressed quite specifically as
a program objective by Spain: to reduce the prevalence
of high faecal shedders or faecal shedding. Sweden,
which was considered to be free of paratuberculosis, had
the same objective but it would apply only if the disease
were to be detected through surveillance. Reducing con-
tamination of the human food chain (32% of countries),
and the related objective (in two of these countries plus
two others) of protecting markets for animal products
was the next most common objective, meaning that 9 of
22 countries (41%) had an expressed objective related to
product quality. Reducing spread to new farms or re-
gions and certification or assurance of herds to provide
a low risk source of stock including replacement stock,
were each expressed by 27% of countries. Reducing eco-
nomic losses and improving animal health, welfare and
farm biosecurity were expressed by 18 and 9% of coun-
tries, respectively. National or regional eradication of para-
tuberculosis was an objective in only two countries (9%)
(Norway and Sweden) while in three countries (14%)
(Germany, the Netherlands and South Africa), eradication
at herd level was an objective that could be chosen by a
farmer and in one region of Belgium (Wallonia, with 120
herds participating out of 3000) regional eradication was a
goal. Research on paratuberculosis and increasing educa-
tion/awareness were not commonly expressed as objec-
tives (9 and 4.5% of countries, respectively).
Performance indicators for control programs
Thirteen of 22 countries (56%) had performance indica-
tors for their control program (Table 10). The most
Fig. 3 Inclusion of advice on paratuberculosis in herd health programs, and availability of veterinary advice for individual animals in countries
with and without a control program for paratuberculosis
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common goal was an increase in the participation rate
of herds in the control program (ten countries) followed
by meeting targets in the number of low risk, free or cer-
tified herds (5) and reductions in the number of infected
animals or clinical cases detected (5). Norway, which
had an eradication program, included active surveillance
targets and completing farm-level post eradication
checks as primary objectives. Sweden, which had ad-
vanced beyond this to a surveillance program, used par-
ticipation rate as the main performance indicator.
Review of control programs
The control programs of 13 countries had been subject
to review at intervals ranging from annually (three
countries) to periodically every two to five years (four
countries) and only once in the others. The one-time
reviews were conducted as long ago as 2009 in the
United States of America and as recently in 2015 in
Germany. As a result of review there were substantial
changes to the programs in four countries, changes to
the objectives in three countries and changes to the
operations and methods in nine countries. The pro-
grams were not terminated in any country as a result
of review.
Leadership of control programs
Leadership of the control programs among the 22 coun-
tries was extremely variable, ranging from seven distinct
components in Canada to a simpler structure with just
one major nominated leader in 11 countries. In seven of
these single-leader programs the leader was the govern-
ment, while in the remaining four, leadership was pro-
vided by a private organization, which in the case of
Republic of Ireland was comprised of representatives
of government and other sectors. There is likely to be
some overlap in these classifications due to represen-
tation of government in private organizations and vice
versa, and in general the programs of most countries
had diverse representation with 11 having more than
one type of leadership component. Government was
represented in at least 15 countries, farmer organiza-
tions in at least 11, a veterinary organization in six,
an industry milk organization in four, and an industry
meat association in three.
Table 9 Objectives of paratuberculosis control programs among 22 countries
Objective No. countries % countries
Reduce prevalence of MAP (equivalent term = control) 17 77.3
Reduce incidence of clinical cases 10 45.5
Reduce MAP contamination in the human food chain/improve consumer safety 7 31.8
Provide confidence or assurance to, or safeguard markets (including export) 4 18.2
Reduce spread to new farms or regions 6 27.3
Certification of freedom or provide information on low risk herds as a source of replacement stock 6 27.3
Reduce production/economic losses 4 18.2
Risk management: determine risk in a herd; allow trade/marketing with an accredited or specified
risk level; reduce within herd spread
4 18.2
Provide individual farmers with tools to manage JD (where manage = prevention or control) 3 13.6
Eradication of MAP from herds that aim to do this 3 13.6
Research including determination of prevalence or incidence 2 9.1
Elimination of high shedders or reduction of faecal shedding 2 9.1
Improve animal health and welfare and farm biosecurity 2 9.1
Country-level eradication (detect, control then eradicate) 2 9.1
Region-level eradication (detect, control then eradicate) 1 4.5
Education and awareness 1 4.5
Table 10 Performance indicators for paratuberculosis control
programs in 13 countries
Performance indicator No. countries
Participation rate of herds 10
Number of low risk, free or certified herds 5
Incidence – the number of infected animals
or clinical cases detected
5
Prevalence - within herd 3
Number of infected herds 2
Number of MAP shedders 2
Number of herds in a test and cull plan 1
Animal production data 1
Active surveillance targets met 1
Program review and post eradication checks completed 1
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Funding of programs
The sources of funding for control programs were di-
verse and varied considerably between countries. Leader-
ship was fully funded by government in 8 of 22
countries and partially funded by government in another
eight countries. The next most common source was
farmer organizations (eight countries) (see Additional
file 2: Table S10). Program operations on the other hand
were most likely to be funded wholly or partially by
farmers (17 countries) or farmers in conjunction with
government (eight countries) compared to government
alone (three countries) (see Additional file 2: Table S11).
Participation and incentives
Participation in the control program was compulsory in
at least some regions of nine countries (40%), and volun-
tary in the other 13 countries. In Australia, participation
was compulsory only in some states (Northern Territory,
South Australia and Western Australia) while in the rest
of the country it was voluntary except for notification of
the disease. Compulsory participation was legislated in
Austria, Japan, Norway and Switzerland and covered by
ordinances in one region of Germany. Components of
control that were compulsory varied from country to
country according to the objectives of the program. For
example, vaccination of sheep was mandatory in Iceland,
where it was believed that without the legislation paratu-
berculosis would be much more widespread. Active sur-
veillance was mandatory in Japan. In South Africa,
animals diagnosed with MAP had to be isolated and
slaughtered under the supervision of a state official, in-
contact animals had to be tested and infected herds/
flocks had to be placed under quarantine. Both Norway
and Sweden had legislation that made reporting of any
suspicion of MAP mandatory, and if MAP is detected
(in any species), stamping-out, contact tracing, and
eradication is compulsory.
Incentives for participation were identified in 15 coun-
tries (68%), comprising ten out of the 13 (77%) with vol-
untary programs and five out of the nine (56%) with
compulsory programs (p = 0.29). Incentives for participa-
tion included higher prices or higher demand for ani-
mals or animal products (four countries), avoidance of
penalties such as market access restrictions for non-
participation (ten countries), subsidised test costs (five
countries) and various other incentives. In some coun-
tries, the restrictions were onerous, as were the conse-
quences of diagnosis which could mean exclusion from
the market. For instance, in the Netherlands, dairy
farmers are required by their milk processors to obtain a
preferred herd status in a paratuberculosis control
programme [53], meaning that herds have to be tested
periodically and any test-positive cattle have to be culled.
Incentives and penalties in these countries are listed in
Additional file 2: Table S12.
Financial assistance to farmers
At country level, full or partial financial support, assist-
ance or compensation to farmers for one or more oper-
ational aspects of the control program was provided in
one or more species between 2012 and 2018 in 12 of the
22 countries (55%). Due to program review processes,
this may have begun or ceased during this period, for ex-
ample in Australia financial support was available to beef
farmers until 2016, then ceased. Among the 12 countries
in which financial support was provided, the compo-
nents covered included the cost of testing (11 countries),
the cost of culling infected livestock (seven countries),
and the value of culled livestock (eight countries). All
three components were covered in four countries, two
were covered in six countries and one was covered in
two countries.
Practices and tools used in control programs
Control programs for paratuberculosis in the 22 coun-
tries were generally multi-component and involved
many possible practices and tools (Table 11). Those
employed depended on the objectives and hence also on
the prevalence of paratuberculosis within the country.
The number of tools employed ranged from 2 to 11
among countries with 16 (73%) of the 22 countries
employing five or more of the practices and tools listed
in Table 11.
Table 11 Practices and tools used in control programs for
paratuberculosis in 22 countries listed by frequency of inclusion
Tool No. of
countries
% of
countries
Cull clinical cases 19 86.4
Hygienic rearing of neonates/juvenile
livestock
17 77.3
Farm-level biosecurity to prevent
introduction of infection
17 77.3
Test and cull subclinical cases 16 72.7
Environmental and pasture management 14 63.6
Communications program 14 63.6
Herd/flock assurance certification 13 59.1
Research program 11 50.0
Vaccination 7 31.8
Regional biosecurity to prevent introduction
of infection
5 22.7
National biosecurity to prevent introduction
of infection
4 18.2
Other 4 18.2
Stamping out infected herds/flocks 3 13.6
Individual animal assurance certification 3 13.6
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Reflecting the fact that most countries were tackling
relatively high burdens of paratuberculosis, practices and
tools used by more than half of the countries were the
culling of clinical cases (19 countries with a control pro-
gram, 86%), hygienic rearing of neonates/juvenile live-
stock (17 countries, 77%), farm level biosecurity
planning to prevent introduction of infection (17 coun-
tries, 77%), testing and culling of subclinical cases (73%)
and environmental and pasture management (64%). In
contrast stamping out infected herds/flocks (14%) was
uncommon and applied only where the disease was con-
sidered to be rare. Some practices and tools would apply
regardless of prevalence and included communications
and education (64%), and herd/flock assurance or certifi-
cation (59%). Half of the countries had a research pro-
gram. Less than one third of the countries employed
vaccination (32%), regional biosecurity planning to pre-
vent introduction of infection (23%), national biosecurity
planning to prevent introduction of infection (18%) or
individual animal assurance certification (14%). Other
tools were employed by 18% of countries, including
Switzerland, where any animal traffic to and from the in-
fected farm was forbidden, clinical cases as well as their
sucking calves/lambs were culled, and the housing was
cleaned and disinfected before the animal traffic ban was
lifted from the farm. In Sweden, surveillance was the
major tool to maintain assurance of national freedom.
Vaccination was not permitted in some countries such
as Denmark, required a special permit to be used in
France, Germany and Spain, and was not applied to all
species in countries where it was used, for example
sheep and goats only in Australia, Spain and the
Netherlands, and sheep only in Iceland and South
Africa.
Implementation of the control program at farm level
Among the 22 countries, the on-farm implementation of
the control program was conducted by private veterinar-
ians or para-veterinary staff (e.g., private animal health
officers) in eight countries, both private and government
veterinarians or para-veterinary staff in seven countries,
and by government veterinarians or para-veterinary staff
(e.g., animal health officers) in six countries. In the
Netherlands, this work was done by a private
organization in cooperation with private veterinarians.
Manuals, protocols and definitions
A publicly available manual describing details of the
control program such as the case definitions, rules and
procedures of the control program was available for 18
of 22 countries. In Spain, the Government of Galicia
provided such information for farmers on-line, but in
other regions information would be provided to farmers
upon request. There was no manual in South Africa but
instead a legislative document. Citations for the informa-
tion that was available for each country are provided in
Additional file 2: Table S13. Definitions for terms used in
control programs such as “infected” and “diseased” ani-
mals/herds and “control” and “eradication” were often
provided in the manuals or other sources of information
(77 and 52% of these countries, respectively). Detailed de-
scriptions of the methods of diagnosis/surveillance, con-
trol and the rules/regulations associated with control
programs were almost always provided in the manuals or
other sources of information (96, 95 and 90% of countries
where these components were applicable, respectively).
Diagnostic tests and their purposes in control programs
Diagnostic tests used in control programs in any species
in the 22 countries with a control program are sum-
marised in Table 12. Serum ELISA, faecal PCR or cul-
ture and pathology were most commonly specified,
while agar gel immunodiffusion, complement fixation
test (both on blood), intradermal skin test and faecal ZN
smear were least often specified. In other species, tests
were applied in bison in Canada and Switzerland,
water buffalo in Italy and water buffalo in Japan and
Switzerland. Other types of tests included testing of
environmental faecal samples in six countries
(Australia, Canada, France, Germany, New Zealand
and United States of America), ELISA on small pools
of milk or blood samples in some regions of France,
a pooled milk ELISA in one region (Lower Saxony) of
Germany, and the serological Enferplex test on goat
bulk milk in Norway.
The tests specified by most countries for individual ani-
mal diagnosis were serum ELISA, individual faecal PCR or
culture and pathology; for individual animal certification/
assurance they were individual faecal PCR or culture and
serum ELISA; for herd-level screening they were serum
ELISA, pooled faecal PCR and individual milk ELISA and
for herd-level certification/assurance they were serum
ELISA, individual or pooled faecal PCR and individual
milk ELISA (Table 13). The complement fixation test
(CFT) was used in five countries. In three, CFT was used
when required for livestock export (South Africa, Thailand
and USA). In Japan the CFT was used not only when re-
quested by importing countries but also for individual
diagnosis in small ruminants (sheep and goats) combined
with a Johnin skin test. In the Netherlands in 2016 and
2017 the CFT was a minor test, used on only 1% of all
submitted sera; the majority of these CFT tests were done
in relation to breeding/artificial insemination in parallel to
ELISA testing, and for livestock imports or exports.
Communication, extension and education activities
While a defined communications program was present
in 14 of 22 countries (Table 11), communication,
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extension or education and training activities were in-
cluded within the control programs of 17 (77%) of
the 22 countries within the period 2012–2018. The
specific target audience for this activity was farmers
(nine countries), veterinarians (12), government repre-
sentatives (2) and stakeholders in general (3) and
while a consistent objective was to increase awareness
the means of diffusion of information included web-
sites, conferences and seminars, field days and
newsletters.
Research activities
Research was included within control programs in 12
(55%) of 22 countries within the period 2012–2018. The
most common research objectives related to improving
diagnostic tests and/or diagnostic test validation (ten
countries), epidemiological research such as risk factors,
transmission dynamics and environmental survival of
MAP (4), pathophysiology (3), disease control (3), vac-
cination (3) and economics (3). Research on prevalence,
microbiology, farmer attitudes, food safety, animal
Table 12 Types of diagnostic tests used in paratuberculosis control programs in 2012–2018 in each type of livestock. Data are the
number of countries among the 22 countries with control programs, sorted by frequency of test
Test Cattle - dairy Cattle - beef Sheep Goats Camelids Deer - farmed Other Not used
Serum ELISA 17 17 9 10 1 3 3
Faecal PCR - individual 18 17 13 12 6 9 3 4
Faecal culture - individual 13 13 9 9 6 9 3 5
Pathology 16 15 13 14 8 11 3 6
Faecal PCR - pooled 12 10 5 4 2 3 10
Milk ELISA - individuals 10 1 2 11
Faecal culture - pooled 8 8 5 4 3 3 12
Milk ELISA - bulk milk 6 1 15
Environmental faecal test - culture or PCR 6 2 1 2 16
Complement fixation test 5 5 4 3 2 3 1 17
Faecal ZN smear 4 4 3 3 2 3 2 18
Other 1 1 20
Intradermal skin test 1 1 1 1 21
Serum AGID 1 21
Table 13 Purposes of use of each type of test among control programs in 22 countries. Data are the number of countries, sorted
by frequency of test
Test Individual animal
diagnosis
Individual animal
certification/ assurance
Herd-level screening Herd-level certification/
assurance
Other
purpose
Test is not
used
Serum ELISA 17 2 14 9 2 3
Faecal PCR - individual 18 8 9 8 2 4
Faecal culture - individual 17 3 5 5 1 5
Pathology 15 1 1 2 2 6
Faecal PCR - pooled 3 11 6 10
Milk ELISA - individuals 10 11 6 1 11
Faecal culture - pooled 3 8 4 12
Milk ELISA - bulk milk 6 1 1 15
Environmental faecal test -
culture or PCR
1 1 6 4 16
Complement fixation test 4 1 2 17
Faecal ZN smear 4 1 2 1 1 18
Other 2 20
Intradermal skin test 1 21
Serum AGID 1 21
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genetics and closing general knowledge gaps were in-
cluded in one or two countries each. Seven developed
countries had research programs on paratuberculosis
that were conducted independently of control programs
(Denmark, Ireland, Japan, the Netherlands, Switzerland,
United Kingdom and United States of America). How-
ever, in these countries the interaction between research
and control programs varied between complete inde-
pendence (for instance Switzerland) to closely linked
(for instance, Ireland). Taken together, research on para-
tuberculosis that would be available to stakeholders was
present in 18 (82%) of 22 countries with control
programs.
Results and success of control programs
The results of control programs operating between 2012
and 2018 were publicly available in 13 (59%) of 22 coun-
tries. Examples of the types of outcomes that were re-
ported included incidence of paratuberculosis in sheep
(Australia) and deer (New Zealand) based on abattoir
surveillance, number of suspect and confirmed cases
and farms (Austria, Japan), weekly test prevalence data
for dairy cattle (Denmark), numbers of participating
dairy (Germany, the Netherlands) or deer (New Zealand)
farms, and lists of certified farms (Australia, United
Kingdom).
The control program was reported to be successful in
16 (73%) of 22 countries. It was too early to tell in three
countries and in three countries outcomes could not be
assessed or it was unclear if success had been achieved.
Of the countries that reported success, 13 commented
that their program objectives had been or were being
met while some mentioned specific outcomes such as
market access maintained (2), prevented clinical cases
(2), or farmers satisfied (2). In addition, four countries
with successful outcomes acknowledged specific prob-
lems: declining numbers of farms in market assurance
programs, the winding back of research and the national
control program in general (Australia); herd-level preva-
lence did not diminish (Belgium); voluntary continuation
of the program among producers was much lower than
hoped for and funding dried up (Canada); the
programme has benefited only a small minority of herds,
with most herds not being in any JD control programme,
therefore it is unlikely that the programme has had any
significant impact on the individual animal or herd-level
prevalence in the region (United Kingdom).
Community and stakeholder support
In more than two thirds of countries with a control pro-
gram, there was active community stakeholder support
from one or more sectors including farmer organizations
(82% of 22 countries), government (77%), veterinary or-
ganizations (73%) and private veterinarians (73%)
(Table 14). Industry organizations for milk and individ-
ual farmers were supportive of control programs in the
majority of the countries (73 and 64%, respectively). In-
dustry organizations for meat, livestock trading and food
processing were supportive in at least 32 to 40% of
countries. Note that absence of recorded support from
these stakeholder sectors in different countries did not
mean that there was opposition, and in some countries
it was uncertain whether or not there was support from
some sectors (Table 14).
There was recorded support for control programs
from at least three (range three to nine) of these stake-
holder sectors in each of 19 countries (86%) (see Add-
itional file 2: Table S14). Japan (government), South
Africa (meat industry) and the United States of America
(industry-milk) had active support from only one sector.
Measurement of support from stakeholders was gener-
ally informal and subjective. In most countries it
depended on feedback obtained during direct engage-
ment or meetings with stakeholders or was evidenced
through receipt of ongoing funding. In Iceland, for ex-
ample, it was generally understood that there was sup-
port from all stakeholders and sectors, but it was not
formally recorded.
In Australia, a large variance in support among stake-
holders was reported; it ranged from actively engaged
and supportive through to actively opposed to any sort
of program. Similarly, in France support from farmers
was reported to be heterogeneous. In Germany (Lower
Saxony), there was divergence within and between sec-
tors: the government in one region supported the pro-
gram by enacting an ordinance and although the milk
industry, farmer collectives, veterinary associations, pri-
vate veterinarians and individual farmers initiated the
program and were closely involved in its development,
not all farmers and veterinarians were in support of the
program. The attitudes among the other stakeholders/
beneficiaries towards the control program were diverse.
Table 14 Sources of stakeholder support by sector for
paratuberculosis control programs in 22 countries. Data are the
number and % of countries
Sector Number %
Farmer organization 18 81.8
Government 17 77.3
Industry organization - milk 16 72.7
Veterinary organization 16 72.7
Private veterinarians 16 72.7
Individual farmers 14 63.6
Industry organization - meat 9 40.9
Industry organization - livestock trading 7 31.8
Food processing industry 7 31.8
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In Switzerland it was recognised that the small percent-
age of farmers that had animals with clinical signs sup-
ported the control program, but there were no data on
the opinion of the other farmers. In the United States of
America, support between farming sectors differed: there
was strong support and lobbying for control program
funding by the dairy industry, but less activity from the
beef cattle industry.
Discussion
Analysis of the data in this study revealed that the global
prevalence of paratuberculosis is high and therefore
should be of great concern: in about half the countries
more than 20% of herds and flocks were infected. Preva-
lence exceeded 40% even in some developed countries.
Under reporting was common as was under-estimation
of prevalence. Many countries, regardless of their UNDP
development index rank, were unaware of the preva-
lence of paratuberculosis in their herds and flocks (Add-
itional file 2: Table S3). Furthermore, the prevalence of
paratuberculosis within infected herds and flocks often
is “guesstimated”, and apparent and true prevalence is
not often differentiated. Thus many of the data in Add-
itional file 2: Table S4 may be underestimates. For ex-
ample, in New Zealand, little knowledge exists about the
prevalence of infected animals in the infected herds,
whereas the annual incidence of clinical cases, which is
the frequency of the final stage of the disease, is com-
monly < 1%. Subclinical infection is much more com-
mon, and to illustrate this point the true within-herd
prevalence among four dairy herds with few clinical
cases in 2010 was actually 6, 7, 15 and 19% [151]. In
deer herds in New Zealand, while < 1% of adults died
each year (an example of incidence), 45% were MAP cul-
ture positive from lymph nodes (an estimate of preva-
lence) [152].
One of the striking features of paratuberculosis is the
variation in prevalence and incidence, regardless of the
scale at which it is measured, be it national, regional,
between-herd or even within-herd. The variability is due
to many factors, including host species and management
systems. However, it is important to note that the distri-
bution, prevalence and incidence of paratuberculosis has
not yet stabilised in many places, because MAP con-
tinues to spread into and within countries, industries
and farms, and the transmission dynamics are deter-
mined by very long incubation periods [66].
In any country, the resources required to control para-
tuberculosis must be drawn from a finite pool of re-
sources, and therefore the control effort must be
justified and prioritised relative to other needs in animal
health and indeed to the broader needs of the industry.
Those needs may be determined by a variety of objective
factors, including for example the need to reduce
economic losses due to the burden of disease, the need
to ameliorate animal welfare concerns or the need to
meet market access specifications. Clearly the reasons
for controlling paratuberculosis that were expressed by
many of the countries with a control program addressed
these needs. The rules mandated by membership of an
economic entity such as the EU, membership of rules-
based organizations such as the WTO and OIE, adher-
ence to historical practice, or merely following the lead
from nearby countries may also determine what is done
or not done. In this study lack of resources of one kind
or another was the most common reason among 26
countries for not implementing paratuberculosis control.
Simply put, there were other priorities for the available
resources. A significant finding was the absence of con-
trol measures in relatively under-developed countries;
often these had large animal populations and arguably
from a human development perspective would benefit
the most from an animal health program. Veterinary ad-
vice to farmers on individual cases was characteristically
missing in these countries too. Countries without para-
tuberculosis controls of any kind will suffer the greatest
impact to human wealth and human health through lost
production of animal protein and potential zoonotic
impacts.
Paratuberculosis is a notifiable disease in most coun-
tries, probably because it is listed by the OIE whose
member countries (most countries) have a reporting ob-
ligation which requires incidence data. However, lack of
guidance from the OIE beyond the reporting require-
ment allows self-determination with respect to the con-
trol of paratuberculosis at country level; there are no
OIE guidelines for paratuberculosis [61]. The OIE has
existed since 1924 and has 182 member countries dis-
tributed on all continents. Its mandate includes elabor-
ation of intergovernmental science-based standards for
disease prevention and control. In contrast to paratuber-
culosis, strict OIE requirements exist for market access
and international trade with respect to bovine tubercu-
losis [153]. Perhaps it was not surprising that we found
control programs for bovine tuberculosis to be common
while those for paratuberculosis were present in less
than half the countries. Beyond bovine tuberculosis
there are many other priority diseases, but we found that
there was no correlation between engaging in control of
these diseases and having a control program for paratu-
berculosis. This seems to be inconsistent, since paratu-
berculosis causes substantial production losses,
diminished animal welfare and potential zoonotic risk all
of which may affect market access. The latter was
highlighted recently in Australia through two events, the
first being the selective suspension in 2015 of exports of
live cattle from farms under investigation of MAP infec-
tion in northern Australia, a region thought to be free of
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the disease, with disruption to a key market in Indonesia.
The second event was a trade ban imposed by Japan on
importation of live Australian breeder cattle due to detec-
tion of paratuberculosis in Australian cattle during their
quarantine in Japan in 2016. The former event preceded a
review of the national bovine Johne’s disease program in
Australia, while the latter event followed this review [154].
Both events caused substantial national industry and gov-
ernment introspection about the best approaches to man-
age paratuberculosis across diverse geographic regions
with different levels of prevalence in different livestock
species, and about which certification practices to adopt
in the future. The need for more information is likely to
be common to many countries and is one justification for
the present study.
A potential complication in control of mycobacterial
diseases is the existence of wildlife reservoirs. Wildlife
play a significant role in the maintenance of M. bovis in-
fections in domestic stock but the situation for paratu-
berculosis is unclear. Although leakage of MAP from
farms may lead to wildlife becoming infected, the role of
wildlife in the MAP infection cycles of farmed livestock
is unproven and we did not explore transmission of
MAP between wildlife and farmed ruminants in this
study. However, numerous species of free-living wildlife,
including monogastric species and carnivores, were re-
ported to be exposed to and infected with MAP (Add-
itional file 2: Table S5). These data are not exhaustive
and reviews of MAP in free-living ruminant and non-
ruminant wildlife are available [56, 63, 155].
The sizes and complexities of the animal populations
at risk of paratuberculosis were extraordinary. About
20% of countries had more than 10 million cattle, sheep
or goats, all countries had several types of farmed rumi-
nants and two thirds had six or seven types. Conse-
quently, there were multiple husbandry systems in most
countries and commonly there were tens of thousands
of individual farms per country. The challenges for dis-
ease control in this landscape are enormous as paratu-
berculosis can spread between livestock species, farms,
regions and countries prior to any clinical evidence,
while controls need to be implemented at a small scale,
i.e. farm level.
One of the limitations of this study is its large scale.
For some countries, separate regional data were aggre-
gated from the questionnaire into country-level data (see
materials and methods), and this led to loss of some de-
tail. For other countries such as Australia and Colombia,
which have significant regional differences in both ani-
mal populations and paratuberculosis prevalence, the na-
tional data lack granularity. This can only be overcome
by separate, detailed national reviews of paratuberculo-
sis. To partially offset the loss of information, summaries
are provided for selected countries in Additional file 4.
Just under half (46%) of the countries that participated
in this study had a control program for paratuberculosis,
the existence of which was justified most commonly on
animal health grounds. But more than two thirds of
these 22 countries were addressing concerns about mar-
ket access, and one third had public health aims. The
latter driver was overt in a minority of countries, but
was probably concealed within the market access driver
in the others. For example, in Ireland, the principal con-
cern was to meet the expectations of international cus-
tomers who operate in food safety sensitive markets, i.e.
trade risk management, so public health was an indirect
driver. Overall there were great differences between
countries with respect to acknowledgment of human ex-
posure to MAP from the livestock sector. For example
the precautionary principle was invoked in the control
programs of the United Kingdom and Japan, but public
health was not overtly mentioned in the control program
of Australia [154]. These inconsistencies are remarkable
and point to the need for international guidance.
The Wingspread Statement on the Precautionary
Principle was promulgated at a meeting in Racine, Wis-
consin on 26 Jan 1998 and states “when an activity raises
threats of harm to human health or the environment,
precautionary measures should be taken even if some
cause and effect relationships are not fully established
scientifically” [156]. Application of the precautionary
principle to MAP exposure in some countries appears to
have led to a combination of mandatory government or
industry-mandated animal disease control efforts aimed
at protecting public health.
The organization, funding and leadership of paratuber-
culosis control programs in the different countries were
quite varied, but there was consistency in objectives be-
cause so many countries had a significant burden of
paratuberculosis to deal with. As 77% of countries aimed
to reduce prevalence, there tended to be emphasis on
culling clinical and subclinical cases. In contrast, where
paratuberculosis was absent (Sweden), the primary activ-
ity was surveillance, and eradication measures would be
undertaken there if paratuberculosis was detected. Swe-
den’s program may be considered a surveillance pro-
gram. Only 2 of 22 countries (Norway and Sweden) had
sufficiently low (or zero) prevalence that they could aim
to eradicate the disease.
There was government funding of program leadership
in about two thirds of countries, but actual operations
tended to be funded by farmers and not by government
alone. The majority of countries (60%) had voluntary
control programs, and overall programs were supported
by incentives for joining, plus financial compensation
and/or penalties for non-participation. In Norway and
Sweden, compulsory activity to detect (and if found) to
eradicate MAP was financially supported by the state.
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Government support was considered to be an important
foundation for surveillance of MAP in Sweden and one
reason why prevention, control, and eradication of MAP
in Sweden has been successful. Thus, special regulations
supported by legislation may be required to control
MAP.
There was strong evidence that ongoing review and
modification of programs occurred over time and just
over half had objective performance criteria. However,
herd participation rates may not be a good measure of
performance. A feature of successful disease control pro-
grams is a decline in the percentage of affected herds
over time, while the participation rate may decrease for
economic reasons alone. This has been seen in the sheep
industry in Australia where some farmers prematurely
cease vaccination against paratuberculosis to reduce
their production costs. They do this soon after the inci-
dence of clinical cases decreases, whereas successful
control requires long term vaccination [111]. Participa-
tion rates in certification programs such as the Market
Assurance Program in Australia fell over time due to
progressive detection of subclinical infections in some
herds and market failure to reward participation. These
features were perceived negatively by herd owners and
were seen as a failure of the national program. However,
another perspective is that the rigour of the testing in
the Market Assurance Program was effective surveil-
lance, thereby enhancing other objectives of the national
program. Arguably the reduction in the annual incidence
of clinical cases as a performance indicator, while poten-
tially beneficial in terms of reducing transmission, may
lead to a false sense of security, premature cessation of
strict control measures and has been confused with re-
ducing prevalence (i.e. the prevalence of subclinical in-
fection may be high in the absence of a high incidence
of clinical cases). Furthermore, trends in apparent preva-
lence can be an inappropriate measure of progress in a
test-and-cull scheme, because culling test-positive indi-
viduals after a test round will reduce the likelihood of
detection using that test at the subsequent test round.
The practices and tools for control of paratuberculosis
are well known. Culling of clinical cases, test and cull of
subclinical cases, hygienic rearing of young livestock,
biosecurity, and environmental pasture management
were dominant approaches. However, vaccination was
seldom used, despite its potential appeal given the diffi-
culty of other management approaches, the recognised
efficacy of vaccines and the scale of the need driven by
high prevalence and large population sizes in some
countries. Only seven countries with a control program
included vaccination. The reasons were not explored in
this study, but it is likely that interference of paratuber-
culosis vaccines with immunological tests for bovine tu-
berculosis is a major reason for not vaccinating cattle
[108, 109]. Paradoxically, the multilateral international
trade rules applying to tuberculosis [153] are probably
holding back control of paratuberculosis for which there
are invisible rules [61]. But this does not explain the lack
of widespread use of vaccination in small ruminants in
which efficacy has been proven [106] and long term ap-
plication has been shown to have substantial benefits
[111]. In 2000, Benedictus [113] had already concluded
that paratuberculosis can be eradicated in sheep and
goats by systematic vaccination together with biosecurity
measures, while in cattle eradication can be achieved by
vaccination followed by culling of faecal culture positive
individuals and culling of entire herds if severely af-
fected. In Australia, where bovine tuberculosis has been
eradicated, vaccination of infected dairy or beef herds
against paratuberculosis is likely to be cost-effective [35].
The application of laboratory tests in control programs
has undoubtedly been beneficial and they are instrumen-
tal in test and cull programs. Serum ELISA and faecal
tests for MAP were the most commonly applied tests re-
gardless of livestock species and they were used for
many purposes. Nevertheless, poor diagnostic tests or
lack of testing capacity were cited as reasons for not
having a control program by seven countries. These rea-
sons can be a constraint to disease control, and so im-
proving diagnostic tests or test validation were research
objectives in around half of the countries with a control
program.
Essential factors for consideration in disease control
programs were listed by Thrusfield [150]. They include
adequate knowledge of the disease (cause, maintenance
and transmission), diagnostic feasibility and adequate
surveillance as well as farmer/public opinion (stake-
holder support). In addition, Houe et al. [157] empha-
sized the importance of socioeconomic factors such as
motivation, logistics, resources and communication.
Communication with farmers in particular has been
highlighted as a need in several studies on compliance
with control recommendations [86, 87]. Consequently,
most countries have specific communication, extension
and education activities within their control programs
for paratuberculosis. Improving knowledge is also im-
portant; about half the countries had active research ob-
jectives, many with emphasis on diagnosis. Knowledge
gaps and research needs for paratuberculosis were
reviewed recently [158].
While greater than two thirds of countries with a con-
trol program for paratuberculosis acknowledged support
from various sectors of the community and government,
there was also evidence of community polarisation
within sectors. Uninfected producers in some economies
may actually gain from the production losses in infected
herds [54] which can also lead to disharmony. The ex-
perience articulated by Australia, France and Germany
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was that impacts of disease control measures can be felt
differently by different parts of the farming community.
Furthermore, community engagement can lead to dra-
matic change in policy. In Australia, community and
government support of the control and prevention pro-
gram declined between 1995 and 2016 amid rising criti-
cism from some sectors about inequitable social,
financial and personal impacts on affected producers. In
response, the organisations representing the farming in-
dustries, as well as State governments, shifted the na-
tional program away from one with stringent regulatory
measures to one in which individual farmers can choose
to manage their own risk of paratuberculosis according
to market demands, while observing civic (common law)
responsibilities with respect to biosecurity. The national
program is complemented by regulatory controls in the
low-prevalence jurisdictions of Western Australia and
Northern Territory where there was community demand
for such measures.
An important aspect of this study was to assess
whether control programs for paratuberculosis were
considered to be successful by the countries that had
them. The results were publicly available in almost 60%
of countries and success measured against objectives
was reported in 73% of countries during self-assessment.
Some countries acknowledged the difficulties and prob-
lems in measuring success.
Establishing a sustainable control programme is diffi-
cult. This was the experience in developed countries
such as the United States of America, Canada and
Australia where control programs have expired in recent
years, regardless of apparent or partial successes. Ultim-
ately, cessation follows a redirection of resources which
may be for any number of reasons. Securing funding for
what inevitably needs to be a long term control activity
is a problem. In some countries the food processing in-
dustries and farmers do not seem to have the desire or
the capacity to provide funding. The test of public good
(public versus private benefit) that is needed for govern-
ment to become involved may not have been proven and
the discussion between government and industry may
have not reached a sufficient maturity for parties to
agree to a funding model. This is not assisted by the am-
biguous public health status of MAP, which has resulted
in the conclusion that controlling MAP is an animal
health responsibility (there are proven zoonotic condi-
tions that attract public health funding) [58–60].
Recommendations for future control programs
Paratuberculosis is a common disease with direct and in-
direct animal health, animal welfare and economic im-
pacts. It may also affect public health. There is no doubt
that it will spread and increase in prevalence and inci-
dence if it is not controlled [32, 159, 160]. Therefore,
control of this disease would seem to be important, but
impediments exist: the lack of an international animal
health code for paratuberculosis, the inconsistent ap-
proaches to public health assessments between coun-
tries, the lack of data on true prevalence and the long
time frames required for control measures. Once a com-
mitment is made to controlling the disease there are a
suite of issues that should be addressed. Recommenda-
tions and possible actions are as follows:
1. International guidelines and procedures for MAP
The adoption of an international code for paratubercu-
losis by OIE, leading to universal acknowledgment of the
principles and methods of control in relation to endemic
and transboundary disease is essential. The lack of any
general guidelines for paratuberculosis control as well as
fragmentation of the paratuberculosis control programs
in different countries creates a vacuum where animal
health authorities do not know what to recommend and
where governments can avoid costly actions if they wish
to. This dialogue will require a discussion about conflicts
between the control programs for bovine tuberculosis
and paratuberculosis that arise due to diagnostics for bo-
vine tuberculosis, specifically the intradermal test [161].
Elevation of the international discussion of the public
health significance of MAP beyond health departments
of individual countries is also needed. This should be
through forums such as World Health Organization
(WHO), building upon existing, credible, unbiased as-
sessments [58–60] to obtain a consensus statement.
2. Surveillance
Uniform enhanced surveillance to establish or avoid
overlooking the true prevalence of MAP is needed in
many countries. This knowledge will help guide coun-
tries to the appropriate stages of control or eradication,
and enable the selection and prioritisation of objectives
as well as appropriate tools.
3. Performance indicators
Without performance indicators the industry or
organization funding the control program may become
less motivated to continue, but the negative aspects of
using participation rates or clinical incidence data as
signs of achievement should lead to exploration of other
measures. One measure could include prevalence data
based on objective surveillance and testing. The number
of paratuberculosis notifications to the OIE relative to
the size of the national herd, and reductions in true
prevalence based on surveillance could be used. For
countries declared free of paratuberculosis, objective
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monitoring data would be used for ongoing self-
declaration of freedom from paratuberculosis.
4. Research
Diagnostic tests must be improved to assist surveil-
lance as well as test and cull strategies. While new tests
appear from time to time, such as the phage-test for vi-
able MAP in blood or milk [162], or improved culture
methods [163], critical evaluation should be required
using stringent guidelines before tests are used in con-
trol programs [164]. Improved diagnostic tests are also
needed for bovine tuberculosis, to differentiate infection
from mycobacterial vaccination, and thereby enable
wider use of existing commercial vaccines for
paratuberculosis.
Evaluating the role of potential domestic or wild reser-
voir hosts for MAP, and the means of preventing spread
of MAP from farmed livestock to wildlife populations is
important. It may avert for paratuberculosis the prob-
lems experienced with control of bovine tuberculosis in
countries such as the United Kingdom and New Zea-
land, and mitigate collateral damage in valued wildlife
populations from the paratuberculosis epidemic in
livestock.
New methods for studying paratuberculosis may en-
hance discovery of vaccine candidates and diagnostics. A
vaccine that prevents infection may have advantages for
controlling MAP over current vaccines. Direct compari-
sons between test and cull programs and vaccination
programs for MAP are warranted in a range of species
and countries to obtain evidence for application of vac-
cines, particularly where test and cull is impossible due
to the scale of the problem or cultural practices. Vaccin-
ation for MAP may be able to be evaluated efficiently in
developing countries that do not require bovine TB test-
ing of cattle.
5. Holistic approach
How effective will control programs be if the disease is
controlled in only one sector? Some countries in this
study had control programs only for one type of live-
stock, typically dairy cattle, even though the condition
was present in others. In Australia, paratuberculosis
control in sheep has been managed independently from
that in beef cattle despite co-grazing of pastures and evi-
dence both for and against spread of MAP between
these species [112, 165, 166], and control in beef cattle
has sometimes been managed independently from dairy
cattle despite dairy calves entering beef production facil-
ities. Similarly, in countries as diverse as Iceland and
New Zealand there has been exchange of MAP between
different livestock sectors [112, 167]. In New Zealand,
beef cattle and sheep raised together tended to harbor
the same genetic variants of MAP, indicating no
specialization of the agent [167]. While apparent host
preferences of different strains of MAP have been re-
ported [168], it is unclear whether the pathogen can
evolve to take advantage of opportunities to establish
new niches for its persistence. For these reasons an hol-
istic approach is required for control of paratuberculosis.
6. Improved communication among interested parties
The success of any control program is dependent on
the synergistic actions of farmers, veterinarians, diagnos-
tic laboratories, breeding associations, food processors
and state veterinary authorities among other stake-
holders. All the involved parties need to communicate
and share knowledge with each other. All parties should
have all of the relevant information and understand all
of the advantages of paratuberculosis control as well as
all of the risks that failure to control may present now
and in the future. All these stakeholders need to create a
mutually supportive and transparent environment to
allow control of paratuberculosis.
7. Sustainability of control programs
As is the case for bovine tuberculosis, the time frame
for successful control of paratuberculosis is measured in
decades. The need for sustainability of such an effort ar-
guably must be determined and justified economically.
Unless direct consumer or other market demands pro-
vide appropriate price signals, control programs will be
under-valued by the farming industries and not sus-
tained. Research studies to better understand and fore-
cast consumer and market demands/pricing with respect
to the animal welfare and public health aspects of MAP
infection are warranted.
Bias
Bias of various kinds is a potential problem in any sur-
vey. Chain referral sampling was used in this study to
find people with relevant knowledge on paratuberculosis.
This is a purposive, non-random sampling method and
is therefore subject to selection bias. However, the ad-
vantages of its use were that people with “rare” know-
ledge and specific expertise and interest were able to be
located through social networks, and it avoided other
types of bias. Both geographic and Western cultural bias
were overcome to some extent as participants were well
distributed globally and usually were local people
employed in institutions belonging to the country. Live-
stock producing countries outside the major developed
economies of Europe and North America were repre-
sented although there were major gaps such as Russia,
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China and much of Africa. “Experts” were nominated
but their recruitment was coordinated by one person
(Whittington) who issued an invitation with information
on the eligibility criteria and maintained all communica-
tions. This approach may have resulted in both the high
response rate and the completion by most participants
of most questions in the extremely detailed and lengthy
questionnaire. Most of the participants were researchers
or animal health policy developers and were aware of
the requirement for objective data for scientific publica-
tions. Arguably they were diligent because they were
aware that they would be a co-author of this paper from
the beginning. Given the eligibility criteria, participants
had good understanding of the control program in their
country, reasons for establishing the program, objectives
of the program, and funding of the program. Therefore,
this information is unlikely to be biased.
Bias in provision of specific and detailed information
was minimised through use of a structured question-
naire. This captured mainly categorical and ordinal re-
sponses; there were relatively few open questions.
Importantly, “unknown” was able to be selected as a re-
sponse to many questions, to avoid forcing an opinion in
the absence of data, and sources of information were re-
corded and are documented in the supplementary tables.
To this extent the results of the study are transparent.
Questions about disease burden required quantitative
data which often originated from a credible source (gov-
ernment report or a peer reviewed publication) and thus
were unlikely to be biased. However, it is possible that
selection bias may have led to estimates of disease preva-
lence in some countries higher than the actual preva-
lence of the disease, because of the particular focus of
the experts. Alternatively, it could be underestimated in
some countries due to prestige or social desirability bias.
Data on prevalence of paratuberculosis are generally
problematic, and the elevation of local or regional data
for presentation at national level is acknowledged to be
a limitation of this and other studies on paratuberculo-
sis. Some of the information presented here was derived
from participants’ opinions, for example on the success
of the control program, or community and stakeholder
engagement; opinions can be biased and therefore
should be interpreted with caution.
Conclusion
Based on this review of 48 countries, paratuberculosis
was a common disease that will continue to spread if it
is not controlled. However, there were many challenges
for disease control flowing from the need to deal with
very large animal populations spread across large num-
bers of herds, over a long time-frame. Many countries
have an unknown prevalence and distribution of paratu-
berculosis, which can only be resolved by surveillance.
Although we did not estimate the economic losses,
based on data in the literature (see Background) they
would already be considerable. Formal control programs
were underway in 22 mostly developed countries, and
were justified most commonly on animal health
grounds, protecting market access and public health.
However, articulation of a public health objective was
very variable between countries. The most common ob-
jective was prevalence reduction, but several countries
had a national or regional eradication program following
successful control, and Sweden and Norway were con-
sidered to be in a surveillance phase. While control was
voluntary in 60% of countries, programs were often sup-
ported by incentives and/or penalties for non-
participation. Government funding was commonly in-
volved and may be essential for sustainability; certainly,
the availability of funding for long-term control activities
was problematical. However, when assessed against their
objectives, control programs were reported to be suc-
cessful in 73% of 22 countries.
To enhance the control of paratuberculosis globally
will require leadership, commencing with an agreed
international code for paratuberculosis, describing the
principles and methods of control. All ruminant live-
stock industries must be involved to prevent one indus-
try becoming a reservoir of MAP for another industry.
Public health assessments of MAP between countries
also require an unbiassed harmonisation. Paratuberculo-
sis detection and control will be improved through re-
search on improved diagnostic tests and epidemiology.
Vaccination against paratuberculosis, and the competing
objectives of bovine tuberculosis and paratuberculosis
control that exist because of use of the skin test for bo-
vine tuberculosis surveillance, require re-evaluation.
There are winners and losers in any control program,
and for this reason all stakeholders must be educated
about long-term goals and benefits in order to create a
mutually supportive environment to allow for control of
paratuberculosis.
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